Loading asset research
Instil Bio Inc. Common Stock
TILNasdaq · USD · StocksQuote as of · Exchange session not verified$7.38
+0.27%
Today
TIL
Loading 1D prices…
Market cap
$50.1M
Volume
34K
52w high
$25.8952w low
$5.67Company profile
Instil Bio Inc. Common Stock
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Dallas, TX, United States
Employees
17
Fiscal year end
1231
CIK
1789769
Session & valuation
Open$7.32
Previous close$7.36
Day high$7.67
Day low$7.32
30-day avg. volume8.5K
Outstanding shares6.8M
Diluted EPS-$10.70
Latest annual period
P/E (trailing)-0.69
P/E (forward)-0.50
Price / book0.45
Beta1.92
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TVGNTevogen Inc. Common Stock | $47.9M | $0.00 | — | -$8.08 | +0.96% | Unrated |
| ELOXEloxx Pharmaceuticals Inc. Common Stock | $54.1M | $0.00 | — | -$5.34 | -3.26% | Buy |
| MGXMetagenomi Therapeutics Inc. Common Stock | $43.8M | $25.2M | -348.54% | -$2.36 | 0.00% | Buy |
| IMAImageneBio Inc. Common Stock | $57.8M | $800K | -5668.63% | -$9.64 | +1.50% | Hold |
| EXOZeXoZymes Inc. Common Stock | $58.5M | $0.00 | — | -$1.09 | +2.13% | Unrated |